ArticleFrontiers in medicine2025

Characteristics of adverse events and clinical risks of intravenous immunoglobulin: a pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS).

Zhen Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.